Our aim is to screen for ophthalmological (glaucoma, AMD, nystagmus) and neurological (dementia) conditions by offering clinicians one device that can perform multiple rapid neuro-ophthalmic eye examination tests. Our unique BulbiHUB platform and BulbiCAM currently offers the user multiple tests to screen for glaucoma, age-related macular degeneration (AMD) and nystagmus. Ultimately our BulbiCAM will include multiple tests to screen for both ophthalmological and neurological conditions.
Our technology maintains good vision and cognitive health across a lifetime.